Is Klaviyo HIPAA Compliant for a Telehealth or Health Brand?

Last updated: July 13, 2026 · By Jason Garrett, Founder, Coast Studio. Not legal advice. Full legal landscape: The State of HIPAA Tracking.

No. Klaviyo does not sign Business Associate Agreements, which closes the HIPAA path entirely: no configuration, plan tier, or careful field hygiene makes Klaviyo an acceptable home for PHI. This lands hard on DTC health and telehealth brands, because Klaviyo is the default growth stack for e-commerce — and many health brands arrived at their compliance question years after their email list, flows, and revenue were already living there.

Why this bites harder than it sounds

The instinctive response is "we just won't put health data in Klaviyo." But look at what a health brand's Klaviyo account accumulates by default: purchase history (which is the health data when the products are treatments, medications, or condition-specific), browse-abandonment and site-tracking events from health-revealing pages via Klaviyo's onsite script, quiz and intake answers synced from onboarding flows, and segments that are effectively condition lists ("purchased ED treatment, 90 days"). For a telehealth company, nearly every field is health-linked. For a supplements or wellness brand outside HIPAA, the same data is "consumer health data" under state laws like Washington's MHMDA — separate opt-in consents, private right of action — and the FTC's GoodRx and BetterHelp actions were built on exactly this category of flow.

The three workable patterns

1. Migrate to a BAA-signing platform. Purpose-built HIPAA email/SMS providers (Paubox among them) and enterprise platforms that sign BAAs on qualifying tiers (see our HubSpot breakdown) can run lifecycle marketing on health data lawfully. This is the clean answer for telehealth.
2. Split the stack. Keep Klaviyo for genuinely non-health commerce only, with a hard data firewall: no health-product events, no onsite tracking script on health pages, no synced intake data. Honest assessment: this discipline is hard to maintain and easy to erode — it works for brands where health SKUs are a side catalog, not the business.
3. De-identify at the boundary. Some healthcare CDPs (e.g., Ours Privacy) exist to sit between your systems and marketing tools, controlling and minimizing what reaches non-BAA destinations. Powerful, but requires real data-engineering intent — and consent still governs what's permissible to send.

What doesn't work: staying put and hoping. Email platforms are discoverable in every tracking audit and every demand-letter investigation, and "our ESP had our patient list with purchase history" is not a sentence counsel can fix after the fact.

FAQ

Will Klaviyo sign a BAA if we're big enough? As of this writing Klaviyo doesn't offer BAAs at any tier. If that ever changes, the configuration and consent questions above still apply.

Is SMS different from email here? The platform analysis is the same (PHI in a non-BAA system is the violation), and SMS adds TCPA consent requirements on top. Same migration logic, more urgency.

We're pre-launch — can we just start on Klaviyo and migrate later? Migrating a live lifecycle program is far more painful than starting on a compliant platform. If your products are health-linked, build it right the first time.

Lifecycle marketing migrations for health brands are a Coast Studio specialty — talk to us.